Charles S. Haworth

Sep 1, 2024 | openres.ersjournals.com | Michael R Loebinger |Stefano Aliberti |Charles S. Haworth |Christoph Lange

FootnotesProvenance: Submitted article, peer reviewed. Authors contributions: M.R. Loebinger and J. van Ingen conceived and developed the surveys for all rounds of voting. All panellists and authors discussed and shaped the content for voting Rounds 2 and 3. All authors discussed the content of the manuscript from the face-to-face meetings; they also conceived and developed the outline and all manuscript drafts. All authors critically reviewed and approved the final draft for submission.

Jul 1, 2024 | openres.ersjournals.com | James Chalmers |Charles L. Daley |Anthony De Soyza |Charles S. Haworth

IntroductionNon-cystic fibrosis bronchiectasis (hereafter bronchiectasis) is a chronic and progressive inflammatory disease marked by irreversible bronchial dilatation. Once considered an orphan disease [1], bronchiectasis remains a widely neglected respiratory condition, despite its increased prevalence in recent years [2].

Jun 6, 2024 | erj.ersjournals.com | Stefano Aliberti |Eva Polverino |Charles S. Haworth |Michael R Loebinger

IntroductionImpaired mucociliary clearance is one of the defining features of the clinical syndrome of bronchiectasis [1, 2]. The most frequent symptoms that impact upon patients’ quality of life are cough and sputum production, commonly characterised by secretions with high viscoelasticity [3–5].

Apr 18, 2024 | erj.ersjournals.com | Stefano Aliberti |Felix C. Ringshausen |Charles S. Haworth |Michael R Loebinger

IntroductionBronchiectasis is a chronic inflammatory disease [1, 2]. Although it is recognised that bronchiectasis is composed of multiple phenotypes and endotypes, inflammation has classically been regarded as neutrophilic and patients with higher levels of neutrophilic inflammation have been shown to have worse clinical outcomes [3–5]. Although there are composite severity and prognostic assessment tools for bronchiectasis, there are currently no direct measures of inflammation [5–7].

Apr 12, 2024 | erj.ersjournals.com | Stefano Aliberti |Felix C. Ringshausen |Charles S. Haworth |Michael R Loebinger

FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.